Sanford Burnham Prebys is uncovering the origins of disease
to maximize their impact on human health
needed to solve medicine's most challenging problems
meaningful clinical benefit and growing further discovery
The Latest News
-
Genetic Disorders and Aging
Jerold Chun receives a very special Alzheimer’s grant
The $250,000 award will help Chun's lab explore how ancient viruses in our genome could promote Alzheimer's and other neurodegenerative diseases. -
The three-day postdoctoral recruitment event provided professional development, leadership training, networking opportunities and mentorship sessions.
-
Drug Discovery
Without this protein, tuberculosis is powerless
Sanford Burnham Prebys researchers have uncovered the structure of an important protein for the growth of tuberculosis bacteria. The study could help yield new treatments for the disease. -
Last weekend, Sanford Burnham Prebys helped support local cancer research by participating in Padres Pedal the Cause.
-
Researchers from Sanford Burnham Prebys have revealed a new function for a previously-known immune molecule, a discovery with implications for the treatment of autoimmune and gastrointestinal diseases.
-
In the News
From zebra fish to bacteria, Diabetes Research Connection celebrates a decade funding novel ideas
San Diego group has provided more than $2 million to early-career scientists across the country conducting maverick research on Type 1 diabetes, including the lab run by developmental geneticist Duc Dong at Sanford Burnham Prebys. -
Stimulating immune responses can help the body fight cancer and improve the effects of other treatments.
-
Genetic Disorders and Aging
Randal Kaufman included in $12 million initiative to improve hemophilia treatment
The new project will help researchers better understanding why current gene therapy treatments aren't working. -
Children's Health
Rare Disease Day gathers scientists, doctors and families
After a break during the pandemic, Rare Disease Day is back and better than ever. -
How a one-of-a-kind kid and his family stay connected during the pandemic.
-
Having worked for decades to improve the lives of children with rare diseases, Hudson Freeze is still on the case.
-
Differences in how DNA repair genes are expressed as a result of environmental impacts may help to explain why Black women in the US have a higher mortality from breast cancer than white women.
Living History
NCI-Designated Cancer Center
Earning the NCI designation in 1981 — just five years after its modest start in downtown La Jolla — our Cancer Center truly is "the miracle on Torrey Pines Mesa."

Next Generation
Svasti Haricharan and Brooke Emerling featured in GEN
Svasti Haricharan, Ph.D. and Brooke Emerling, Ph.D. are leveraging cellular signaling to potentially change the way we treat breast cancer.

Living History
Along the road to discovery
It was in 1979 when Eva Engvall asked Erkki Ruoslahti a question that would change their lives forever: "Wouldn't it be great to work in San Diego?"

Next Generation
Graduate student Katja Birker's research doesn't miss a beat
"There is no magic wand to cure congenital heart conditions–we have to do the research."

Calendar
Seminar
Yuliya Pylayeva-Gupta, Ph.D., UNC-Chapel Hill
Seminar
Cyrus Ghajar, Ph.D., Fred Hutch Cancer Center
Seminar
Symposium
Seminar
Seminar
Seminar
COVID-19 matching gift campaign
The power of investing in human health
Dinah Ruch is accelerating our COVID-19 efforts with a generous matching gift that doubles all donations dollar for dollar up to $500,000.

Our Partners in Discovery
We can't do it alone
Our annual Rare Disease Day symposium strengthens the global network of families, physicians and researchers to better understand and fight rare diseases in children.

Our Partners in Discovery
Getting to the finish line faster
Thanks to the philanthropic vision of Stuart and Karen Tanz, a unique collaboration seeks new treatments for diseases such as Alzheimer’s, dementia and Parkinson’s.

Our Partners in Discovery
New hope for autoimmune disease
Our partnership with Lilly—centered around a high degree of interaction—has already produced an immune therapy now in clinical trial.

Our Partners in Discovery
A master class in collaboration
Meet T. Denny Sanford, Conrad Prebys and Malin Burnham: three people who know we're stronger when we work together.
